GlobeStar Therapeutics Corporation GSTC
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 124.11K
- Vol
- 300.00K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
MAX chart
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Jul 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| SMA: Bullish | Aug 1, 2020 | 6 years ago |
| SMA: Bearish | Feb 1, 2019 | 7 years ago |
| SMA: Bullish | Sep 1, 2018 | 8 years ago |
| SMA: Bearish | Oct 1, 2017 | 9 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| SMA: Bearish | Dec 1, 2016 | 9 years ago |
| SMA: Bullish | Sep 1, 2016 | 10 years ago |
| SMA: Bearish | Oct 1, 2015 | 11 years ago |
| SMA: Bullish | Sep 1, 2015 | 11 years ago |
| SMA: Bearish | Dec 1, 2013 | 12 years ago |
| SMA: Bullish | Aug 1, 2013 | 13 years ago |
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 11, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| Jun 28, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Mar 11, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Jan 19, 2024 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 17, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
| May 31, 2023 | Mar 1, 2023 | 0.00 | 0.00 | — | — |
News
- Globestar Therapeutics Update on Project Amethyst(TM) and Recent Financials
- GlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis Treatment
- Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare to Manage Clinical Trial, Regulatory Filings, Manufacturing and Sales in MEA Region for Multiple Sclerosis Treatment
- GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets
- GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.
- GlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple Sclerosis
- GlobeStar Therapeutics Corporation Unveils New Corporate Website and Branding Campaign
- GlobeStar Therapeutics Corporation To Be Seen In The Washington Football Team Yearbook All Season
Your note
Sign in to keep a note on GSTC — it syncs with the Stock Master app.